Home/Filings/4/0000950170-23-042406
4//SEC Filing

Seelenberger Alexander A. 4

Accession 0000950170-23-042406

CIK 0001796129other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:09 PM ET

Size

5.2 KB

Accession

0000950170-23-042406

Insider Transaction Report

Form 4
Period: 2023-08-11
Seelenberger Alexander A.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-08-11$0.95/sh+10,500$9,96830,280 total
Footnotes (2)
  • [F1]Represents a weighted average purchase price. Actual purchase prices ranged from $0.9374 to $0.9499 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
  • [F2]Includes 2,287 shares and 5,000 shares of common stock acquired on May 13, 2022 and May 12, 2023, respectively, under the Vincerx Pharma, Inc. 2021 Employee Stock Purchase Plan.

Documents

1 file

Issuer

Vincerx Pharma, Inc.

CIK 0001796129

Entity typeother

Related Parties

1
  • filerCIK 0001832562

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:09 PM ET
Size
5.2 KB